Świętokrzyskie Centrum Psychiatrii W Morawicy
Kielce, Poland
Treatment & access
- Treatments offeredesketamine (Spravato)
- Access routepublic_reimbursed
- Price informationCovered by NFZ (drug programme B.147)
- ReimbursementNFZ drug programme B.147 - leczenie chorych na depresję lekooporną How reimbursement works in Europe →
- Phone+48 41 366 97 55
- Websitehttps://morawica.com.pl/szpital/centrum-zdrowia-psychicznego-kielce
About this provider
This is the Kielce site of Świętokrzyskie Centrum Psychiatrii in Morawica, located at ul. Kusocińskiego 59. Since November 2020 it has operated a Mental Health Center under the national pilot program, combining a psychiatric ward, an adult mental health outpatient clinic with registration-coordination points, a general day psychiatric ward and a community treatment team for adult residents of Kielce. NFZ data shows this Kielce location as a separate entry of drug program B.147, providing fully reimbursed esketamine for treatment-resistant depression.
Services & programs
- Psychiatric ward (Oddział Psychiatryczny OP) with admission room at ul. Kusocińskiego 59
- Adult mental health outpatient clinic with registration (Przychodnia Psychiatryczna dla Dorosłych)
- General day psychiatric ward
- Community treatment team and CZP registration-coordination point
- Additional CZP point at ul. Piekoszowska 54 in Kielce
- Esketamine treatment for treatment-resistant depression under NFZ drug program B.147
Common questions
How is this different from the Morawica entry of the same provider?
Same hospital, different campus: this entry is the Kielce site at ul. Kusocińskiego 59 (adult outpatient registration +48 41 366 97 55, admission room +48 41 366 97 44), while the main campus is in Morawica at ul. Spacerowa 5. Choose whichever location is confirmed for your program visits.
Do I need a referral for the B.147 program?
Program qualification is done by a psychiatrist. Contact the Kielce adult psychiatric outpatient registration or the CZP coordination point (+48 41 366 97 56) with your prior treatment documentation; the criteria are age 18-75 and failure of at least two adequate antidepressant trials in the current episode.
Verification
- License / registryNFZ B.147
- Sourcehttps://api.nfz.gov.pl/app-itl-api/queues?case=1&benefit=LECZENIE%20CHORYCH%20NA%20DEPRESJ%C4%98%20LEKOOPORN%C4%84
- Last verified